`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`
`MEDA PHARMACEUTICALS INC. and
`CIPLA LTD.,
`
`
`
`
`
`Plaintiffs,
`
`v.
`
`
`APOTEX INC. and APOTEX CORP.,
`
`)
`)
`)
`)
`)
`C.A. No. 14-1453-LPS
`)
`
`)
`)
`)
`)
`
`JOINT STATUS REPORT
`
`Pursuant to the April 14, 2015 Scheduling Order (D.I. 126, ¶ 14), Plaintiffs Meda
`
`
`
`
`
`
`
`
`
`
`
`
`
`Defendants.
`
`Pharmaceuticals Inc. and Cipla Ltd. (collectively, “Meda”) and Defendants Apotex Inc. and
`
`Apotex Corporation (collectively, “Apotex”) jointly submit this Interim Status Report.
`
`I.
`
`NATURE OF THE MATTERS IN ISSUE
`
`
`
`At issue in this case is Apotex’s ANDA seeking approval to market a 137 mcg strength
`
`azelastine hydrochloride and 50 mcg strength fluticasone propionate combination nasal spray—a
`
`generic version of Plaintiff Meda’s DYMISTA® drug product—before the expiration of Plaintiff
`
`Cipla’s U.S. Patent Nos. 8,163,723 and 8,168,620.
`
`
`
`II.
`
`STATUS OF THE ACTION
`
`While there are no outstanding motions at this time, the parties submitted a Joint Letter to
`
`the Court on January 20, 2016, stating that Plaintiffs intend to add an additional patent to the
`
`case—U.S. Patent Application No. 14/661,720. The USPTO anticipates that this patent will issue
`
`on February 16, 2016. In connection with the addition of this patent, the Court rescheduled the
`
`Markman hearing for April 29, 2016. The parties are continuing negotiations and anticipate
`
`{01087565;v1 }
`
`1
`
`
`
`Case 1:14-cv-01453-LPS Document 86 Filed 02/11/16 Page 2 of 2 PageID #: 1912
`
`submitting a stipulation to file an amended complaint and a proposed revised schedule that will
`
`preserve the current trial dates.
`
`The parties have served and responded to interrogatories and document requests. Each
`
`party has also substantially completed document production, and will continue to supplement as
`
`needed. The parties have noticed depositions but have not yet agreed to dates for depositions.
`
`The parties are continuing to cooperate to resolve their discovery disputes and do not currently
`
`anticipate a need for judicial intervention in this regard.
`
`A call has been scheduled with Judge Burke on February 29 to discuss potential
`
`mediation.
`
`
`
`The parties are available to discuss the status of this case with the Court at the Court’s
`
`convenience.
`
`
`ASHBY & GEDDES
`
`/s/ Andrew C. Mayo
`_________________________________
`Steven J. Balick (#2114)
`John G. Day (#2403)
`Andrew C. Mayo (#5207)
`500 Delaware Ave., 8th Floor
`P.O. Box 1150
`Wilmington, DE 19899
`(302) 654-1888
`sbalick@ashby-geddes.com
`jday@ashby-geddes.com
`amayo@ashby-geddes.com
`
`Attorneys for Plaintiffs
`
`Dated: February 11, 2016
`
`
`POTTER ANDERSON & CORROON, LLP
`
`/s/ David E. Moore
`___________________________________
`Richard L. Horwitz (#2246)
`David E. Moore (#3983)
`Bindu A. Palapura (#5370)
`1313 North Market Street
`Hercules Plaza, 6th Floor
`Wilmington, DE 19801
`rhorwitz@potteranderson.com
`dmoore@potteranderson.com
`bpalapura@potteranderson.com
`
`Attorneys for Defendants
`
`{01087565;v1 }
`
`2